Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Grapefruit Flavonoid Naringenin for the Treatment of HCV Infection

NCT01091077 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01091077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01091077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Grapefruit Flavonoid Naringenin for the Treatment of HCV Infection
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2009
Completion date
August 31, 2013
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hcv, hcv infection, hepatitis c, hepatitis c virus